We are live on ! Find out more

BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights

BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

571 hedge funds and large institutions have $1.18B invested in Bristol-Myers Squibb Company Contingent Value Rights in 2020 Q3 according to their latest regulatory filings, with 68 funds opening new positions, 120 increasing their positions, 186 reducing their positions, and 75 closing their positions.

New

Increased

Maintained

Reduced

Closed

2,672% more call options, than puts

Call options by funds: $15.5M | Put options by funds: $560K

9% less first-time investments, than exits

New positions opened: 68 | Existing positions closed: 75

2% less funds holding

Funds holding: 583 → 571 (-12)

9% less funds holding in top 10

Funds holding in top 10: 11 → 10 (-1)

35% less repeat investments, than reductions

Existing positions increased: 120 | Existing positions reduced: 186

37% less capital invested

Capital invested by funds: $1.89B → $1.18B (-$706M)

Holders

571

Holders Change

-12

Holders Change %

-2.06%

% of All Funds

11.52%

Holding in Top 10

Holding in Top 10 Change

-1

Holding in Top 10 Change %

-9.09%

% of All Funds

0.2%

New

Increased

120

Reduced

186

Closed

Calls

$15.5M

Puts

$560K

Net Calls

+$15M

Net Calls Change

-$8.18M

Top Buyers

Rank	Fund	Capital Flow
1	APM Avidity Partners Management Dallas, Texas	+$48.3M
2	NCM Nantahala Capital Management New Canaan, Connecticut	+$44.1M
3	LCM Laurion Capital Management New York	+$22.1M
4	Janus Henderson Group London, United Kingdom	+$20.3M
5	MP Mangrove Partners Greenwich, Connecticut	+$17.5M

Top Sellers

Rank	Fund	Capital Flow
1	PCM Pentwater Capital Management Naples, Florida	-$44.2M
2	BCM Beryl Capital Management Redondo Beach, California	-$27.6M
3	ACM Abrams Capital Management Boston, Massachusetts	-$24M
4	EC EcoR1 Capital San Francisco, California	-$17M
5	Marshall Wace London, United Kingdom	-$15.7M

#	Name	Holding	Trade Value	Shares Change	Change in Stake
76	76 BNP Paribas Asset Management Paris, France	$1.82M	+$320K	+112,045	+16%
77	BG 77 Bellevue Group Kuesnacht, Switzerland	$1.8M	–	–	–
78	78 National Pension Service Jeonju-Si, Jeollabuk-Do, South Korea	$1.74M	–	–	–
79	AGM 79 Alpine Global Management New York	$1.69M	+$656K	+229,811	+44%
80	80 California Public Employees Retirement System Sacramento, California	$1.65M	–	–	–
81	81 State of Wisconsin Investment Board Madison, Wisconsin	$1.64M	–	–	–
82	82 Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden	$1.61M	+$57.1K	+20,000	+3%
83	OCMI 83 Oaktop Capital Management II Chatham, New Jersey	$1.59M	+$1,000K	+350,000	+99%
84	84 Ensign Peak Advisors Salt Lake City, Utah	$1.55M	+$1.15M	+401,099	+139%
85	85 UBS Group Zurich, Switzerland	$1.55M	-$655K	-229,288	-25%
86	86 D.E. Shaw & Co New York	$1.52M	+$208K	+72,746	+12%
87	87 Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada	$1.47M	–	–	–
88	IFWM 88 Institute for Wealth Management Denver, Colorado	$1.46M	+$319K	+111,548	+21%
89	GL 89 Governors Lane New York	$1.39M	+$314K	+110,000	+22%
90	BHMP 90 Bardin Hill Management Partners New York	$1.33M	-$220K	-77,081	-12%
91	DLA 91 Douglas Lane & Associates New York	$1.33M	-$112K	-39,109	-6%
92	GLAM 92 Gardner Lewis Asset Management Chadds Ford, Pennsylvania	$1.23M	+$143K	+50,000	+10%
93	BCM 93 Beddow Capital Management Jackson, Wyoming	$1.19M	+$145K	+50,925	+11%
94	94 Mitsubishi UFJ Trust & Banking Tokyo, Japan	$1.19M	-$304K	-106,571	-17%
95	95 Truist Financial Charlotte, North Carolina	$1.17M	-$321K	-112,445	-18%
96	96 State of New Jersey Common Pension Fund D Trenton, New Jersey	$1.17M	–	–	–
97	97 Stifel Financial St. Louis, Missouri	$1.15M	-$63.5K	-22,240	-4%
98	SDIC 98 South Dakota Investment Council Sioux Falls, South Dakota	$1.14M	+$58K	+20,300	+4%
99	RCM 99 Redwood Capital Management New York	$1.13M	–	–	–
100	SM 100 Selkirk Management Chatham, New Jersey	$1.13M	–	–	–

BMY.RT Hedge Fund Activity: Q3 2020 in Review

571 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) for Q3 2020, worth a combined $1.18B — down 37% from $1.89B a quarter earlier.

Sellers outnumbered buyers: 75 funds closed out of BMY.RT and 68 opened new positions — a net loss of 7 holders — while 186 trimmed existing stakes and 120 added.

The largest buyer was Avidity Partners Management, adding an estimated $48.3M. The largest seller was Pentwater Capital Management, cutting an estimated $44.2M.

571 institutional investors held Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) as of Q3 2020, down from 583 in Q2 2020.
Funds reported $1.18B of Bristol-Myers Squibb Company Contingent Value Rights stock for Q3 2020, down 37% quarter-over-quarter.
68 funds opened new Bristol-Myers Squibb Company Contingent Value Rights positions in Q3 2020 and 75 closed out, a net change of -7 holders.
The largest Bristol-Myers Squibb Company Contingent Value Rights buyer in Q3 2020 was Avidity Partners Management, an estimated $48.3M added.
The largest Bristol-Myers Squibb Company Contingent Value Rights seller in Q3 2020 was Pentwater Capital Management, an estimated $44.2M sold.

Based on aggregated 13F filings for Q3 2020.

Bristol-Myers Squibb Company Contingent Value Rights BMY.RT